IL146252A0 - Use of gonadotrophin in induction of folliculogenesis - Google Patents

Use of gonadotrophin in induction of folliculogenesis

Info

Publication number
IL146252A0
IL146252A0 IL14625200A IL14625200A IL146252A0 IL 146252 A0 IL146252 A0 IL 146252A0 IL 14625200 A IL14625200 A IL 14625200A IL 14625200 A IL14625200 A IL 14625200A IL 146252 A0 IL146252 A0 IL 146252A0
Authority
IL
Israel
Prior art keywords
folliculogenesis
gonadotrophin
induction
Prior art date
Application number
IL14625200A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL146252(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL146252A0 publication Critical patent/IL146252A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14625200A 1999-05-07 2000-05-05 Use of gonadotrophin in induction of folliculogenesis IL146252A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07
PCT/GB2000/001745 WO2000067778A1 (fr) 1999-05-07 2000-05-05 Gonadotrophines

Publications (1)

Publication Number Publication Date
IL146252A0 true IL146252A0 (en) 2002-07-25

Family

ID=8241371

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14625200A IL146252A0 (en) 1999-05-07 2000-05-05 Use of gonadotrophin in induction of folliculogenesis
IL146252A IL146252A (en) 1999-05-07 2001-10-31 Use of gonadotrophin in the preparation of a medicament for induction of folliculogenesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146252A IL146252A (en) 1999-05-07 2001-10-31 Use of gonadotrophin in the preparation of a medicament for induction of folliculogenesis

Country Status (18)

Country Link
US (2) US7695721B1 (fr)
EP (1) EP1176976B2 (fr)
JP (1) JP4975215B2 (fr)
CN (1) CN1352566A (fr)
AR (1) AR023869A1 (fr)
AT (1) ATE332705T1 (fr)
AU (1) AU4592800A (fr)
BR (1) BR0010709B1 (fr)
CA (1) CA2372714A1 (fr)
DE (1) DE60029318T3 (fr)
DK (1) DK1176976T4 (fr)
ES (1) ES2267531T5 (fr)
HK (1) HK1045261A1 (fr)
IL (2) IL146252A0 (fr)
PT (1) PT1176976E (fr)
SI (1) SI1176976T2 (fr)
TW (1) TWI242440B (fr)
WO (1) WO2000067778A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS21004A (en) 2001-09-12 2006-12-15 Aplied Research Systems Ars Holding N.V. Use of hcg in controlled ovarian hyperstimulation
PL205472B1 (pl) * 2001-09-12 2010-04-30 Serono Lab Zastosowanie hormonu luteinizującego (LH)
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
PL369021A1 (en) * 2001-09-12 2005-04-18 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
CA2515297A1 (fr) * 2003-02-07 2004-08-19 Ambros Valentin Huber Utilisation de la gonadotrophine chorionique humaine dans le traitement des symptomes causes par l'endometriose
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
ES2414705T3 (es) 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (fr) 2010-08-04 2012-02-09 Glycotope Gmbh Hormone folliculostimulante humaine recombinante améliorée
FI2621517T4 (fi) * 2010-09-29 2024-01-03 Ferring Bv Koostumus käytettäväksi hedelmättömyyden hoidossa
WO2012127501A2 (fr) * 2011-03-11 2012-09-27 Sanzyme Limited Composition pour améliorer l'épaisseur endométriale au cours de la stimulation ovarienne
KR20140053991A (ko) 2011-07-18 2014-05-08 아츠 바이올로직스 에이/에스 장기간 작용하는 황체 형성 호르몬 (ｌｈ) 화합물
US20150150497A1 (en) * 2012-07-18 2015-06-04 Mor Research Applications Ltd. Intrauterine device
WO2018080120A1 (fr) * 2016-10-28 2018-05-03 Samsung Electronics Co., Ltd. Procédé et appareil de quantification folliculaire dans des images échographiques 3d
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
JP2002531414A (ja) * 1998-12-01 2002-09-24 アクゾ・ノベル・エヌ・ベー 卵胞発生の改善

Also Published As

Publication number Publication date
ES2267531T5 (es) 2015-11-24
DK1176976T4 (en) 2015-11-02
JP4975215B2 (ja) 2012-07-11
US7695721B1 (en) 2010-04-13
HK1045261A1 (zh) 2002-11-22
IL146252A (en) 2010-06-30
WO2000067778A1 (fr) 2000-11-16
EP1176976A1 (fr) 2002-02-06
SI1176976T1 (sl) 2006-10-31
SI1176976T2 (sl) 2015-12-31
DE60029318T2 (de) 2007-08-09
BR0010709A (pt) 2002-06-04
AR023869A1 (es) 2002-09-04
TWI242440B (en) 2005-11-01
CN1352566A (zh) 2002-06-05
JP2002544168A (ja) 2002-12-24
DE60029318T3 (de) 2016-03-10
US20040224895A1 (en) 2004-11-11
ATE332705T1 (de) 2006-08-15
EP1176976B1 (fr) 2006-07-12
EP1176976B2 (fr) 2015-10-21
DK1176976T3 (da) 2006-11-13
PT1176976E (pt) 2006-11-30
DE60029318T8 (de) 2007-11-22
US7151083B2 (en) 2006-12-19
CA2372714A1 (fr) 2000-11-16
ES2267531T3 (es) 2007-03-16
DE60029318D1 (de) 2006-08-24
BR0010709B1 (pt) 2011-11-29
AU4592800A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
IL146252A0 (en) Use of gonadotrophin in induction of folliculogenesis
IL190220A0 (en) Novel composition and use
IL139030A0 (en) Therapeutic angiogenic factors and methods for their use
HU229606B1 (en) Novel combination of loteprednol and antihistamines
AU2002243363A8 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
EP1224939A4 (fr) Complexe a base d'interferon et son utilisation en medecine
GB9903919D0 (en) Aminophenols and their therapeutic use
HUP0201800A2 (en) Novel calpains and their use
HUP0200775A2 (en) Use of pegylated interferon-alpha in melanoma therapy
GB9906754D0 (en) Therapeutic antibody composition and use
GB9901689D0 (en) Therapeutic antibody composition and use
GB9901682D0 (en) Therapeutic antibody composition and use
GB9907151D0 (en) Therapeutic antibody composition and use
TW392472U (en) Structural improvement in chair
GB0009471D0 (en) Improvements in and relating to workrests
GB9905300D0 (en) Therapy and use of agents in therapy
EG24062A (en) Novel composition and use
GB9905315D0 (en) Therapy and use of compounds in therapy
GB9905307D0 (en) Therapy and use of compounds in therapy
PL109436U1 (en) Therapeutic and rehabilitation table
GB9910892D0 (en) Improvements in and relating to tiling
IL145152A0 (en) Novel protein and its use
TW392478U (en) Improvement in armrest of chair
GB9927119D0 (en) Novel composition and use
GB9912191D0 (en) Novel composition and use